These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 10759916)

  • 21. Montelukast for migraine prophylaxis: a randomized, double-blind, placebo-controlled study.
    Brandes JL; Visser WH; Farmer MV; Schuhl AL; Malbecq W; Vrijens F; Lines CR; Reines SA;
    Headache; 2004 Jun; 44(6):581-6. PubMed ID: 15186302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years.
    Knorr B; Franchi LM; Bisgaard H; Vermeulen JH; LeSouef P; Santanello N; Michele TM; Reiss TF; Nguyen HH; Bratton DL
    Pediatrics; 2001 Sep; 108(3):E48. PubMed ID: 11533366
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial.
    Dahlén SE; Malmström K; Nizankowska E; Dahlén B; Kuna P; Kowalski M; Lumry WR; Picado C; Stevenson DD; Bousquet J; Pauwels R; Holgate ST; Shahane A; Zhang J; Reiss TF; Szczeklik A
    Am J Respir Crit Care Med; 2002 Jan; 165(1):9-14. PubMed ID: 11779723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Montelukast in the prophylaxis of migraine: a potential role for leukotriene modifiers.
    Sheftell F; Rapoport A; Weeks R; Walker B; Gammerman I; Baskin S
    Headache; 2000 Feb; 40(2):158-63. PubMed ID: 10759916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The leukotriene receptor antagonist montelukast and its possible role in the cardiovascular field.
    Hoxha M; Rovati GE; Cavanillas AB
    Eur J Clin Pharmacol; 2017 Jul; 73(7):799-809. PubMed ID: 28374082
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The role of leukotrienes in inflammation and leukotriene inhibitors].
    Kupczyk M; Kuna P
    Pol Merkur Lekarski; 1999 Sep; 7(39):85-93. PubMed ID: 10598480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Montelukast in the treatment of allergic rhinitis: an evidence-based review.
    Nayak A; Langdon RB
    Drugs; 2007; 67(6):887-901. PubMed ID: 17428106
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical evidence with montelukast in the management of chronic childhood asthma.
    Becker A
    Drugs; 2000; 59 Suppl 1():29-34; discussion 43-5. PubMed ID: 10741880
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Montelukast: a review of its therapeutic potential in asthma in children 2 to 14 years of age.
    Muijsers RB; Noble S
    Paediatr Drugs; 2002; 4(2):123-39. PubMed ID: 11888359
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Leukotriene receptor antagonists in children with cystic fibrosis lung disease : anti-inflammatory and clinical effects.
    Schmitt-Grohé S; Zielen S
    Paediatr Drugs; 2005; 7(6):353-63. PubMed ID: 16356023
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Leukotriene modifiers in pediatric asthma management.
    Bisgaard H
    Pediatrics; 2001 Feb; 107(2):381-90. PubMed ID: 11158473
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Leukotriene-receptor antagonists.
    Lipworth BJ
    Lancet; 1999 Jan; 353(9146):57-62. PubMed ID: 10023966
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.